Embryonal rhabdomyosarcoma of the perineum in an adult: A case report

被引：2

作者：

Ka S. ^{[1
]}

Gnangnon F. ^{[1
]}

Dieng M.M. ^{[1
]}

Diouf D. ^{[1
]}

Thiam J. ^{[1
]}

Gaye P.M. ^{[1
]}

Dem A. ^{[1
]}

机构：

[1] Joliot Curie Institute, Dakar

来源：

Journal of Medical Case Reports | / 10卷 / 1期

关键词：

Adult; Embryonal; Immunohistochemistry; Rhabdomyosarcoma;

D O I：

10.1186/s13256-016-1166-2

中图分类号：

学科分类号：

摘要：

Background: We report the case of an adult patient with embryonal rhabdomyosarcoma of the perineum admitted to our practice at Joliot Curie Institute in Dakar. It is a rare tumor at this age and has a bad prognosis at this localization. Case presentation: We describe the case of a 22-year-old African man admitted for a perineal mass that had evolved over 6 months. He complained of tenesmus, obstinate constipation, and dysuria. A clinical examination revealed perineal swelling spread over his anus, scrotum, penis, testicles, and inguinal lymph nodes. A perineal ultrasound and computed tomography scan showed a large mass driving his testicles forward with regional lymph node metastases. An ultrasound-guided biopsy showed embryonal rhabdomyosarcoma on histology and immunohistochemistry, with strong positivity of neural cell adhesion molecule and myogenin while results for cytokeratin AE1/AE3, cluster of differentiation 45, synaptophysin, and chromogranin were negative. Our patient was classified T2N1M1. Outcome was quickly marked by occlusive syndrome and colostomy. Our patient did not opt for chemotherapy and died after 6 months of follow-up. Conclusions: The embryonic RMS of the adult is a rare disease. Despite the sensitivity to chemotherapy and surgery. Localization to perineum remains poor prognosis. © 2016 The Author(s).

引用

共 9 条

[1]

Van Gaal J.C., De Bont E.S., Kaal S.E., Versleijen-Jonkers Y., Van Der Graaf W.T., Building the bridge entre rhabdomyosarcoma in children, teenagers and young adults: The road ahead, Crit Rev Oncol Hematol, 82, 3, pp. 259-279, (2012)

[2]

Newton W.A., Gehan E.A., Webber B.L., Marsden H.B., Van Unnik A.J., Hamoudi A.B., Et al., Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification-Intergroup Rhabdomyosarcoma Study year, Cancer, 76, 6, pp. 1073-1085, (1995)

[3]

Pappo A.S., Shapiro D.N., Crist W.M., Maurer H.M., Biology and therapy of pediatric rhabdomyosarcoma, J Clin Oncol, 13, 8, pp. 2123-2139, (1995)

[4]

Leaphart C.D., Rodeberg D., Pediatric surgical oncology: Management of rhabdomyosarcoma, Surg Oncol, 16, 3, pp. 173-185, (2007)

[5]

Gow K.W., Murphy J.J., Wu J.K., Desa D.J., Metastatic testicular rhabdomyosarcoma - A report of two cases, J Pediatr Surg, 38, 8, pp. E1-E3, (2003)

[6]

Sandler E., Lyden E., Ruymann F., Maurer H., Wharam M., Parham D., Link M., Crist W., Efficacy of ifosfamide and doxorubicin given as a phase II "window" in children with newly diagnosed metastatic rhabdomyosarcoma: A report Intergroup Rhabdomyosarcoma Study Group, Med Pediatr Oncol, 37, 5, pp. 442-448, (2001)

[7]

Pappo A.S., Lyden E., Breitfeld P., Donaldson S.S., Wiener E., Parham D., Et al., Two consecutive phase II trials of irinotecan window alone or in combination with vincristine for the treatment of metastatic rhabdomyosarcoma: The Children's Oncology Group, J Clin Oncol, 25, 4, pp. 362-369, (2007)

[8]

Casey D.L., Wecler L.H., LaQualigli M.P., Meyers P.A., Wolden S.L., Patterns of failure for rhabdomyosarcoma of the perineum and perianal region, Int J Radiat Oncol Biol Phys, 89, 1, pp. 82-87, (2014)

[9]

Fuchs J., Dantonello T.M., Blummenstock G., Koztyla D., Treatment and outcome of patients suffering from perineal/perianal rhabdmyosarcoma: Results from the CWS trials-retrospective clinical study, Ann Surg, 259, 6, pp. 1166-1172, (2014)

← 1 →